Anti-BCL6 antibody (271-320 aa) (STJ96676)
SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
ImmunogenThe antiserum was produced against synthesized peptide derived from the Internal region of human BCL6 at the amino acid range 271-320
General Information
| Short Description | Rabbit polyclonal anti-B-cell lymphoma 6 protein (271-320 aa) for use in IF, WB, IHC and ELISA in Human, Mouse and Rat samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | IF/WB/IHC/ELISA |
| Host | Rabbit |
| Reactivity | Human/Mouse/Rat |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Concentration | 1 mg/mL |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Dilution Range | IF 1:50-200WB 1:500-1:2000IHC-P 1:100-1:300ELISA 1:20000 |
| Formulation | Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Storage Instruction | Store at-20ยฐC for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Target Information
| Gene Symbol | BCL6 |
| Gene ID | 604 |
| Uniprot ID | BCL6_HUMAN |
| Immunogen | The antiserum was produced against synthesized peptide derived from the Internal region of human BCL6 at the amino acid range 271-320 |
| Immunogen Region | 271-320 aa |
| Specificity | Bcl-6 Polyclonal Antibody detects endogenous levels of Bcl-6 protein. |
Additional Info
| Post Translational Modifications | Phosphorylated by MAPK1 in response to antigen receptor activation at Ser-333 and Ser-343. Phosphorylated by ATM in response to genotoxic stress. Phosphorylation induces its degradation by ubiquitin/proteasome pathway. Polyubiquitinated. Polyubiquitinated by SCF(FBXO11), leading to its degradation by the proteasome. Ubiquitinated by the SCF(FBXL17) complex, leading to its degradation by the proteasome: ubiquitination by the SCF(FBXL17) complex takes place when aberrant BTB domain dimers are formed. Acetylated at Lys-379 by EP300 which inhibits the interaction with NuRD complex and the transcriptional repressor function. Deacetylated by HDAC- and SIR2-dependent pathways. |
| Function | Transcriptional repressor mainly required for germinal center (GC) formation and antibody affinity maturation which has different mechanisms of action specific to the lineage and biological functions. Forms complexes with different corepressors and histone deacetylases to repress the transcriptional expression of different subsets of target genes. Represses its target genes by binding directly to the DNA sequence 5'-TTCCTAGAA-3' (BCL6-binding site) or indirectly by repressing the transcriptional activity of transcription factors. In GC B-cells, represses genes that function in differentiation, inflammation, apoptosis and cell cycle control, also autoregulates its transcriptional expression and up-regulates, indirectly, the expression of some genes important for GC reactions, such as AICDA, through the repression of microRNAs expression, like miR155. An important function is to allow GC B-cells to proliferate very rapidly in response to T-cell dependent antigens and tolerate the physiological DNA breaks required for immunglobulin class switch recombination and somatic hypermutation without inducing a p53/TP53-dependent apoptotic response. In follicular helper CD4(+) T-cells (T(FH) cells), promotes the expression of T(FH)-related genes but inhibits the differentiation of T(H)1, T(H)2 and T(H)17 cells. Also required for the establishment and maintenance of immunological memory for both T- and B-cells. Suppresses macrophage proliferation through competition with STAT5 for STAT-binding motifs binding on certain target genes, such as CCL2 and CCND2. In response to genotoxic stress, controls cell cycle arrest in GC B-cells in both p53/TP53-dependedent and -independent manners. Besides, also controls neurogenesis through the alteration of the composition of NOTCH-dependent transcriptional complexes at selective NOTCH targets, such as HES5, including the recruitment of the deacetylase SIRT1 and resulting in an epigenetic silencing leading to neuronal differentiation. |
| Protein Name | B-Cell Lymphoma 6 ProteinBcl-6B-Cell Lymphoma 5 ProteinBcl-5Protein Laz-3Zinc Finger And Btb Domain-Containing Protein 27Zinc Finger Protein 51 |
| Database Links | Reactome: R-HSA-6785807Reactome: R-HSA-6803205Reactome: R-HSA-9614657 |
| Cellular Localisation | Nucleus |
| Alternative Antibody Names | Anti-B-Cell Lymphoma 6 Protein antibodyAnti-Bcl-6 antibodyAnti-B-Cell Lymphoma 5 Protein antibodyAnti-Bcl-5 antibodyAnti-Protein Laz-3 antibodyAnti-Zinc Finger And Btb Domain-Containing Protein 27 antibodyAnti-Zinc Finger Protein 51 antibodyAnti-BCL6 antibodyAnti-BCL5 antibodyAnti-LAZ3 antibodyAnti-ZBTB27 antibodyAnti-ZNF51 antibody |
Information sourced from Uniprot.org